Clinical Trial: Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study
Brief Summary: Cross-linking of the cornea increases the mechanical and biochemical stability of the stromal tissue. The purpose of this study is to assess the effectiveness of riboflavin-ultraviolet light induced cross-linking of corneal collagen in improving visual acuity and reducing progression of keratoconus in the Brazilian population.
Detailed Summary:
Sponsor: Universidade Federal do Rio de Janeiro
Current Primary Outcome:
- Keratometry [ Time Frame: 3 months ]
- BSCVA (Best spectacle corrected visual acuity) [ Time Frame: 3 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Endothelial cell count [ Time Frame: 3 months ]
Original Secondary Outcome: Same as current
Information By: Universidade Federal do Rio de Janeiro
Dates:
Date Received: March 17, 2008
Date Started: February 2007
Date Completion: December 2009
Last Updated: April 22, 2008
Last Verified: March 2008
